About Morningside
Morningside is a venture capital firm founded in 1986. It is primarily based out of Newton, United States. As of Apr 2026, Morningside is an active investor, having invested in 174 companies, with 5 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of SimpliFed Overall, Morningside portfolio has seen 4 unicorns, 14 IPOs and 19 acquisitions including key companies like Agora, CRED and BetterUp. A lot of funds co-invest with Morningside, with names like Wellington sharing a substantial percentage of its portfolio. Morningside has team of 26 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 9 more
Portfolio IPOs
Portfolio Acquisitions
Deals in last 12 months
Morningside's List of Top Investments
Morningside has a portfolio of 174 companies, including 4 unicorns. Their most notable investments are in Semios and Linus Health.Their portfolio spans across United States, China, United Kingdom and 11 more locations. They have invested in Life Sciences, Enterprise Applications, HealthTech and 26 other sectors, across stages such as Series A, Series B and 9 more. Here is the list of top investments by Morningside:1. Agora
Cloud based customer engagement platform. It enables users to connect through video, voice, and interactive broadcasting. It provides developers with APIs, to embed real time voice, video, interactive streaming, chat, and artificial intelligence capabilities into applications. It helps businesses and developers create engaging and interactive experiences.
Key facts about Agora
- Founded Year: 2014
- Location: Guangzhou (China)
- Stage: Public
- Total Funding till date: $55M
- Employee Count: 501 - 1,000 as on Jul 01, 2024
- Investors: HTIF, Access Industries and 16 Others
- Latest Funding Round: Post IPO, May 07, 2022, $*****
- Highlight: Public
2. CRED
Provider of a platform for managing credit cards and payments. The platform offers tools for payment reminders, fee tracking, spending insights, and benefit maximization. It facilitates payments via various methods, including UPI and credit options. The platform also provides credit score monitoring and data encryption for security.
Key facts about CRED
- Founded Year: 2018
- Location: Bengaluru (India)
- Annual Revenue: ₹2,470Cr as on Mar 31, 2024
- Valuation: $*****
- Stage: Series G
- Total Funding till date: $942M
- Employee Count: 904 as on Aug 31, 2025
- Investors: GIC, Dragoneer Investment Group and 90 Others
- Latest Funding Round: Series G, May 29, 2025, $*****
- Highlight: Editors' Pick

3. Eko
Eko offers an AI-based platform for remote monitoring of cardiac health. The solution offered by the company collects real-time patient data and analyses it to generate a report for doctors. The report generated aids in providing proper treatment to patients. The company has also developed products like Duo and Core stethoscopes for heart disease monitoring.
Key facts about Eko
- Founded Year: 2012
- Location: Oakland (United States)
- Stage: Series D
- Total Funding till date: $195M
- Employee Count: 203 as on Mar 31, 2026
- Investors: 10x Group, Artis Ventures and 33 Others
- Latest Funding Round: Grant (prize money), Apr 11, 2025, $*****
- Highlight: Editors' Pick

4. League
League provides a SaaS-based digital platform for employee health benefits. The platform gives employers tools to easily manage their benefits program and deliver healthcare services for employees. The web-based app gives the ability to create personal health spending accounts and tracks employee utilization. It also gives customized offerings for employees, delivered on-site by the best health professionals in the business.
Key facts about League
- Founded Year: 2014
- Location: Toronto (Canada)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $242M
- Employee Count: 103 as on Mar 31, 2025
- Investors: TDM Growth Partners, Royal Bank of Canada and 18 Others
- Latest Funding Round: Series C, Feb 28, 2025, $*****
- Highlight: Editors' Pick
5. BetterUp
Provider of an AI-powered platform delivering personalized coaching and development. The platform offers tools for leadership development, manager performance improvement, and resilience building. It delivers coaching to employees at all levels. The platform aims to align workforce potential with business strategy through interconnected products.
Key facts about BetterUp
- Founded Year: 2013
- Location: Austin (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $628M
- Employee Count: 2,751 as on Jan 31, 2026
- Investors: Wellington, Sapphire Ventures and 30 Others
- Latest Funding Round: Series E, Sep 19, 2024, $*****
- Highlight: Editors' Pick
Morningside's Year-on-Year Investment Trends
Morningside has invested in 175 companies over the last 22 years, with an average of 10 new investments annually in the last 10 years. In 2025, it made 10 investments, while as of Apr 2026, it has made 3 investments in this year. Its most recent first time investment was in Angitia and most recent follow-on round was in SimpliFed.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 2 | 3 |
2025 | 8 | 2 | 10 |
2024 | 1 | 2 | 3 |
2023 | 5 | 1 | 6 |
2022 | 15 | 4 | 19 |
2021 | 27 | 7 | 34 |
2020 | 13 | 4 | 17 |
2019 | 15 | 4 | 19 |
2018 | 5 | 2 | 7 |
2017 | 2 | 3 | 5 |
Morningside's Investments by Stage
Morningside has made 42 investments in Series A stage with an average round size of $23.9M, 36 investments in Series B stage with an average round size of $49.2M and 17 investments in Seed stage with an average round size of $4.49M.Stage of entry | No. of Investments |
|---|---|
Series A | 42 |
Series B | 36 |
Seed | 17 |
Series C | 11 |
Series D | 7 |
Others | 7 |
Note: We have considered here, only first round of investments
Morningside's Investments by Sector
Morningside has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Enterprise Applications, High Tech and Consumer. Notably, it has invested in 141 Tech companies, 119 Enterprise (B2B) companies, 47 Software companies and at least 40 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 61 |
HealthTech | 28 |
Enterprise Applications | 27 |
High Tech | 22 |
Consumer | 20 |
Others | 96 |
Note: We have considered here, only first round of investments
Morningside's Investments by Geography
Morningside has made most investments in United States (77), followed by China where it has made 18 investments.Country | No. of Investments |
|---|---|
United States | 77 |
China | 18 |
United Kingdom | 11 |
Canada | 3 |
France | 3 |
Others | 8 |
Note: We have considered here, only first round of investments
Morningside's recent investments
Morningside has made 3 investments in 2026 so far. SimpliFed and Cognito Therapeutics are the latest among them.Here are the most recent investments by Morningside:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 07, 2026 | United States | Series A | 6820 | ||
Mar 05, 2026 | United States | Series C | 2211 | [+4] | |
Feb 05, 2026 | United States | Series D | 4630 | [+16] | |
Dec 15, 2025 | United States | Series B | 1154 | [+8] | |
Oct 22, 2025 | - | Seed | 1140 |
Unicorns in Morningside's Portfolio
Morningside has 4 unicorns in its portfolio - CRED, BetterUp, Everlywell and others. The most recent unicorn in their portfolio is CRED. It became a unicorn in 2021, 1 years after Morningside first invested in it.Here is a list of unicorns in Morningside's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
79 | Provider of a platform for managing credit cards and payments | 2018 | Bengaluru | Series G | bttowej | ||
71 | Provider of an AI-powered platform delivering personalized coaching and development | 2013 | Austin | Series E | tp{s{vq | ||
60 | Provider of home-based diagnostic tests for the detection of various diseases | 2014 | Austin | Funding Raised | uaaxipq | ||
52 | Online platform for booking vacation rentals | 2012 | Beijing | Series F | wkcykhs |
IPOs and Publicly Listed companies in Morningside's Portfolio
14 of Morningside's portfolio companies have become public. Alamar Biosciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2026 at marketcap of $1.14B and Generate Biomedicines got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $2.04B.Here are Morningside's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 17, 2026 | Sep 08, 2021 | Series B | 2343 | |
Feb 27, 2026 | Nov 18, 2021 | Series B | 5170 | |
Feb 13, 2026 | Feb 01, 2015 | Series B | 3468 | |
Oct 24, 2024 | Sep 2015 | Seed | 8410 | |
Feb 03, 2022 | Jun 16, 2020 | Series D | 3728 |
Acquired companies in Morningside's Portfolio
19 companies from Morningside's portfolio have been acquired. The most recent acquisition were Apellis Pharmaceuticals in Mar 2026 by Biogen for $5.6B.Here are Morningside's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 31, 2026 | Dec 02, 2014 | Series C | 9654 | |
Mar 30, 2026 | Jun 22, 2015 | Series A | 3857 | |
Oct 21, 2025 | - | - | 7456 | |
Aug 20, 2025 | Nov 23, 2021 | Series B | 7201 | |
Aug 05, 2025 | Nov 17, 2022 | Series A | 7806 |
Team profile of Morningside
Morningside has a team of 26 members including 2 Partners, 1 Venture Partner and 4 Principals located in United States. Morningside's team sits on the board of 2 companies.Here is a list of top team members in Morningside:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | Anaconda, Linus Health and 1 more | ||
Partner | - | - | ||
Venture Partner | - | - | ||
Principal | Boston | - | ||
Principal | Cambridge | - | ||
Principal | Boston | - | ||
Principal | Boston | - |
Co-investors of Morningside
Over the past 22 years, 899 investors have co-invested in Morningside's portfolio companies. This includes funds and angels.
- Invested before Morningside: Morningside, HHS and 376 others have invested in rounds before Morningside. There are 13 companies where Morningside has invested before Morningside and 13 companies where HHS has invested before Morningside.
- Top Co-investors of Morningside: 240 investors entered a company along with Morningside. These include investors like Wellington (3 companies).
- Invested after Morningside: A total of 281 investors have invested in Morningside's portfolio after their investments. Top Investors include 5Y Capital (6 companies), Alpha Wave Global (3 companies) and Orbimed (3 companies).
Recent News related to Morningside
•
SimpliFed Raises Over $10 Million in an Oversubscribed Series ABakersfield•Apr 07, 2026•Hesperia Capital, SimpliFed, Morningside, Foreground Capital and 1 other
•
Cognito raises $105 million for Alzheimer’s treatment deviceSTAT•Mar 05, 2026•New Vintage Partners, Morningside, IAG Capital Partners, Cognito Therapeutics and 3 others
•
Ampa Raises $8.5M in Pre-A FundingFinSMEs•Oct 22, 2025•Ampahealth, Nexus NeuroTech Ventures, Continuum Health Ventures, Morningside and 1 other
•
Brook.ai Secures $28M to Expand Remote Care Model Across the NationHIT Consultant•Oct 16, 2025•Morningside University, Brook, UMass, Morningside
•
UK diagnostics firm Cyted Health secures $44m series BTech in Asia•Sep 02, 2025•Cyted, Morningside, EQT, British Business Bank and 3 others
•
•
Morningside Ventures Invests in Xealth to Enhance Digital Health IntegrationHIT Consultant•Mar 25, 2025•Xealth, Morningside
•
Accropeutics Secured $12 Million in Series B Plus FinancingPR Newswire•Mar 14, 2025•Accropeutics, Shenzhen Capital Group, Morningside, Suzhou Industrial Park Leading Venture Capital and 1 other
•
•
